VRNA logo

Verona Pharma (VRNA) Total Liabilities

Annual Total Liabilities

$58.84 M
+$29.84 M+102.89%

31 December 2023

VRNA Total Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Total Liabilities

$251.33 M
-$14.52 M-5.46%

30 September 2024

VRNA Quarterly Total Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

VRNA Total Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+102.9%+768.5%
3 y3 years+204.1%+653.4%
5 y5 years+309.4%+1333.0%

VRNA Total Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+204.1%-5.5%+768.5%
5 y5 yearsat high+336.1%-5.5%+1923.9%
alltimeall timeat high>+9999.0%-5.5%>+9999.0%

Verona Pharma Total Liabilities History

DateAnnualQuarterly
Sept 2024
-
$251.33 M(-5.5%)
June 2024
-
$265.85 M(+309.5%)
Mar 2024
-
$64.92 M(+10.3%)
Dec 2023
$58.84 M(+102.9%)
$58.84 M(+103.3%)
Sept 2023
-
$28.94 M(-6.2%)
June 2023
-
$30.84 M(-33.5%)
Mar 2023
-
$46.40 M(+60.0%)
Dec 2022
$29.00 M(-24.8%)
$29.00 M(-22.4%)
Sept 2022
-
$37.39 M(-15.0%)
June 2022
-
$43.98 M(+2.3%)
Mar 2022
-
$43.01 M(+11.5%)
Dec 2021
$38.58 M(+99.4%)
$38.58 M(+15.7%)
Sept 2021
-
$33.36 M(-48.0%)
June 2021
-
$64.11 M(+261.4%)
Mar 2021
-
$17.74 M(-8.4%)
Dec 2020
$19.35 M(+43.4%)
$19.35 M(-59.8%)
Sept 2020
-
$48.11 M(+18.2%)
June 2020
-
$40.72 M(+227.9%)
Mar 2020
-
$12.42 M(-8.0%)
Dec 2019
$13.49 M(-6.1%)
$13.49 M(-23.1%)
Sept 2019
-
$17.54 M(+27.4%)
June 2019
-
$13.77 M(+49.0%)
Mar 2019
-
$9.24 M(-35.7%)
Dec 2018
$14.37 M(+10.5%)
$14.37 M(-3.8%)
Sept 2018
-
$14.94 M(-17.4%)
June 2018
-
$18.09 M(-25.4%)
Mar 2018
-
$24.26 M(+86.6%)
DateAnnualQuarterly
Dec 2017
$13.00 M(-9.7%)
$13.00 M(+0.3%)
Sept 2017
-
$12.97 M(+10.1%)
June 2017
-
$11.78 M(-18.2%)
Dec 2016
$14.40 M(+304.0%)
$14.40 M(+753.5%)
June 2016
-
$1.69 M(-52.7%)
Dec 2015
$3.57 M(+336.9%)
$3.57 M(+296.9%)
June 2015
-
$898.30 K(+10.1%)
Dec 2014
$816.10 K(+1.1%)
$816.10 K(+18.2%)
June 2014
-
$690.40 K(-14.4%)
Dec 2013
$806.90 K(+150.5%)
$806.90 K(+204.1%)
June 2013
-
$265.30 K(-17.6%)
Dec 2012
$322.10 K(+33.0%)
$322.10 K(+105.0%)
June 2012
-
$157.10 K(-35.1%)
Dec 2011
$242.20 K(-23.8%)
$242.20 K(-47.3%)
June 2011
-
$459.70 K(+44.6%)
Dec 2010
$317.90 K(-31.5%)
$317.90 K(+225.1%)
June 2010
-
$97.80 K(-78.9%)
Dec 2009
$464.10 K(+277.3%)
$464.10 K(+394.8%)
June 2009
-
$93.80 K(-23.7%)
Dec 2008
$123.00 K(-60.5%)
$123.00 K(-79.0%)
June 2008
-
$587.10 K(+88.5%)
Dec 2007
$311.40 K(+140.8%)
$311.40 K(+121.5%)
June 2007
-
$140.60 K(+8.7%)
Dec 2006
$129.30 K(+527.7%)
$129.30 K(-47.8%)
June 2006
-
$247.60 K(+1101.9%)
Dec 2005
$20.60 K
$20.60 K(+64.8%)
June 2005
-
$12.50 K

FAQ

  • What is Verona Pharma annual total liabilities?
  • What is the all time high annual total liabilities for Verona Pharma?
  • What is Verona Pharma annual total liabilities year-on-year change?
  • What is Verona Pharma quarterly total liabilities?
  • What is the all time high quarterly total liabilities for Verona Pharma?
  • What is Verona Pharma quarterly total liabilities year-on-year change?

What is Verona Pharma annual total liabilities?

The current annual total liabilities of VRNA is $58.84 M

What is the all time high annual total liabilities for Verona Pharma?

Verona Pharma all-time high annual total liabilities is $58.84 M

What is Verona Pharma annual total liabilities year-on-year change?

Over the past year, VRNA annual total liabilities has changed by +$29.84 M (+102.89%)

What is Verona Pharma quarterly total liabilities?

The current quarterly total liabilities of VRNA is $251.33 M

What is the all time high quarterly total liabilities for Verona Pharma?

Verona Pharma all-time high quarterly total liabilities is $265.85 M

What is Verona Pharma quarterly total liabilities year-on-year change?

Over the past year, VRNA quarterly total liabilities has changed by +$222.39 M (+768.53%)